Summary
Cardinal Health, Inc. (CAH) demonstrated robust growth in fiscal year 2002, with a 15% increase in total operating revenue, reaching $44.4 billion. This growth was driven by strong performance across its four key segments: Pharmaceutical Distribution and Provider Services, Medical-Surgical Products and Services, Pharmaceutical Technologies and Services, and Automation and Information Services. The company continued its acquisitive growth strategy, completing several acquisitions that expanded its service offerings and market reach. Despite overall revenue growth, the company experienced a slight decrease in gross margin percentage due to a higher mix of lower-margin pharmaceutical distribution revenue and competitive pricing pressures in its medical-surgical segment. Significant special charges related to integration and restructuring activities impacted net earnings, though the company maintained solid operating earnings. Cardinal Health remains a dominant player in the healthcare supply chain, well-positioned for future growth through strategic acquisitions and operational efficiencies.
Key Highlights
- 1Total operating revenue increased by 15% to $44.4 billion in fiscal year 2002, driven by strong performance across all four business segments.
- 2The company continued its aggressive acquisition strategy, completing several acquisitions in fiscal 2002, notably Magellan Laboratories Incorporated and Boron, LePore & Associates, Inc., to enhance its Pharmaceutical Technologies and Services segment.
- 3Despite revenue growth, the overall gross margin decreased slightly to 9.1% from 9.3% in the prior year, primarily due to a shift towards lower-margin pharmaceutical distribution revenue and competitive pressures.
- 4Selling, general, and administrative expenses as a percentage of operating revenue decreased in fiscal 2002 due to economies of scale and productivity gains, further aided by the cessation of goodwill amortization.
- 5The company incurred significant special charges totaling $138.6 million in fiscal 2002, primarily related to merger integration, distribution center consolidations, and other restructuring activities, which reduced net earnings.
- 6Cardinal Health's market capitalization as of September 9, 2002, was approximately $28.2 billion, with 444.6 million common shares outstanding.
- 7The company anticipates continued dividend payments, with a quarterly cash dividend of $0.025 per common share paid during fiscal year 2002.